Pharmafile Logo

NORD Rare Diseases Breakthrough Summit

October 13, 2020 |  

Gavin Jones, Director of Rare Disease, provides his thoughts on last week’s NORD Breakthrough Summit and a collective need to reduce inequalities in rare disease

Entering A New Era – but what will this new era look like?

It was the NORD congress last week and I wanted to give some thoughts on a key theme that emerged across many sessions. As is seemingly the norm with virtual congress, I was juggling the day job and so this will not be a review of all the sessions. I was grateful that I was able to attend without the transatlantic travel and still have the opportunity watch back several breakout sessions that were missed. There are clearly some benefits to virtual congress!

Pink divider

As with others conferences this year there was plenty to be hopeful about – investment in research in more rare diseases; further progress in gene and therapies where monogenic rare diseases are a logical initial target; significant development in the use of telehealth and so reducing isolation and burden; all the continued passion and commitment within the rare disease community in driving forward change.

Through all this positivity there was a thread that is certainly and significantly holding back effective progress – DISPARITY. COVID-19 loomed large (more so than the European Congress of Rare Disease) and the pandemic has shone a bright light on disparity in the US in terms of healthcare inequalities and its disproportionate impact on certain populations and indeed rare diseases (as being investigated in other countries e.g. the work of ARDent).

A good example of where everything continually tracked back to disparity was a positive session on the role of telehealth to better treat patients living with rare disease. The pandemic has certainly accelerated its use and healthcare professionals described how this had transformed patient consultations with benefits for everyone. Physicians appreciated being able to see a child in their own home where they are more relaxed. Parents appreciated not having to drive five hours to attend a consultation and thereby reducing isolation. However, this won’t benefit the whole community unless, as Professor Susan Berryconcluded, access to good broadband is seen as ‘a right not a privilege’.

Pink divider

How do we overcome these multiple disparities impacting on better outcomes in rare disease? Durhane Wong–Reider led an excellent session on creating sustainable healthcare systems supporting rare disease across the Globe. There are factors, transcending regional borders, that threaten future access to innovation and increasing inequality of access including the removal of legislation that incentivises investment in rare disease research.

If we face similar challenges, perhaps we should fight with one voice? One perspective presented during this session was how the treatment of HIV has been ‘Globalised’ and what lessons can be learned from this. Looking also at how the world has been mobilised in protesting against the disregard of climate change and inequalities based on skin colour also demonstrates that strength in numbers can drive change. As a note, it was great to see another congress in quick succession (the other was the Rare Fair) tackle head on health inequalities based on gender, race and ethnicity with a break-out session well chaired by Eric Dube.

So, returning to the congress theme. Is there an opportunity to harness all the unwavering commitment to better outcomes in rare disease that resides in communities, countries and regions? Are we entering a new era of a Global voice towards collective positive change in rare disease.

Pink divider

Please contact me directly if you would like to discuss our rare experience or our capabilities.

Gavinjones@openhealthgroup.com

LinkedIn

Rare Disease

This content was provided by OPEN Health

Company Details

 Latest Content from  OPEN Health 

Pharmerit rebrands to OPEN Health

OPEN Health is moving to one brand to create a world-class integrated services model

Rare Disease Day 2021

To mark Rare Disease Day 2021 on Sunday 28 February, OPEN Health will be intentionally quiet on all LinkedIn channels from 26 February to 1 March in order not to...

What’s in it for me? How to engage, motivate and support staff with internal training at OPEN Health

If the heart of the medical affairs industry is ultimately improving patient outcomes, internal training is the regenerative liver. Med affairs professionals need to regularly update their scientific knowledge and...

What NORD’s RareInsights® 30-year comparative analysis means to us and our clients at OPEN Health

How fantastic is it to see that the National Organisation for Rare Disorders (NORD) has followed up on a survey undertaken in the late 80’s to pressure test progress and identify...

OPEN Health Group Appoints New Leadership

OPEN Health Group today announced that Rob Barker has been appointed Chief Executive Officer. Rob succeeds outgoing CEO and Co-Founder, David Rowley, who is stepping down after 10 years. A...

OPEN VIE and Pharmerit Bring the Best of Both Worlds to Virtual ISPOR Europe 2020

Join OPEN VIE and Pharmerit – an OPEN Health Company at the ISPOR European Virtual Conference from 16-19 November 2020 to see how we are shaping the healthcare industry with...

OPEN Health brings the Best of Both Worlds to MAPS EMEA 2020

Strategy and execution, data and insight, experience and innovation…what do you look for in an agency partner?OPEN Health is a family of expert practices working in partnership to drive positive...

OPEN Health delivers over 250 virtual activities during COVID-19 – A clear path forward

The COVID-19 pandemic has permanently changed how medical education in the healthcare industry is conducted. Over the last few months, all conferences, medical education and field force deliverables have either...

How Far Do You Want To Go?

Join OPEN Health's virtual careers event on Tuesday 10th November, 15:00–17:00 GMT and discover where a career in medical communications could take you…